Glenn Hanna, MD
Dana-Farber Cancer Institute
4
4
3
N/A
0
15
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Vivek Subbiah, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Nancy Lee, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Xiaozhong Chen, MD
Zhejiang Cancer Hospital
Shared therapeutic areas:
Lin Liao, MD
Qianfoshan Hospital
Shared therapeutic areas:
Alan Ho, MD, PhD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Yifan Zhai, MD, PhD
Ascentage Pharma Group Inc.
Shared therapeutic areas:
Marie-France Langlois, MD
Université de Sherbrooke
Shared therapeutic areas:
Nieto Luis, Master
Site Coordinator of United Medical Group located in Miami
Shared therapeutic areas:
Francesco Perrone, M.D., Ph.D.
National Cancer Institute, Naples
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease
Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia
RAD001 for Patients With Radioiodine Refractory Thyroid Cancer
A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma
All 4 trials loaded